VC  RM Global Partners

     Office Locations:

880 Third Avenue, 16th Floor
New York, NY 10022
Phone: 212-792-6966

Get all office locations for this firm with a National Database subscription or New York Database subscription.


  • Early



  • Financial Services
  • Life Sciences & Healthcare
  • Medical Device



    Founded in 1992, RM Global Partners is an investment banking firm headquartered in New York, New York. The firm assists its clients in mergers and acquisitions, divestitures, spin-offs, joint ventures, structures transactions, spin-offs, private placements, bridge financings, and debt. In addition, RM Global Partners offers services in the areas of business development, project assessment, due diligence, valuations, fairness opinions, and corporate strategy. RMGP Biopharma Investment Fund is a Venture Capital (VC) Fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx. FutuRx is an Israel-based, globally focused drug development platform, founded by Orbimed, Johnson&Johnson and Takeda. RMGP's partnership with the incubator provides access to projects carefully selected by industry professionals, with potential to be first-in-class or best-in-class treatments for therapeutic areas with high unmet need (e.g.: oncology, rare diseases, autoimmune diseases, cardiovascular and metabolic diseases, neurodegenerative and other CNS disorders).



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Bruce Roberts Managing Director
    Lisa Wisniewski Managing Director
    Ted Moon Managing Director
    Yaron Breski Managing Director


    Portfolio companies include:


      Checkpoint Surgical
        web link

      Genome & Company

      ImmPACT Bio

        web link

      R3 Vascular


    Recent News: